The Biopharma CEO Confidence Index is a forward-looking indicator designed to measure C-suite sentiment and confidence in the biopharma industry’s

Situation: An innovative preclinical CRO with multiple disruptive service offerings retained Kineticos to conduct an evaluation of each of their

Situation: A global biopharma company was interested in a comprehensive evaluation of the 503B compounding pharmacy market. The client was

Kineticos conducted primary research via KOLs and an online survey to give our client qualitative and quantitative data to support

Challenge: An international private equity firm was looking at acquiring a Contract Development and Manufacturing Organization and needed to understand

In September, we turn our focus onto Precision Medicine and its impact on the life sciences. Kineticos held 3 conversations

Situation: A privately held emerging biotech company, with an innovative cancer detection test, retained Kineticos to assist them in effectively

Situation: A joint venture between two European companies was looking to maximize the commercial potential of its automated plate reader

Situation: As a follow up to a pricing study, Kineticos was retained by a specialty laboratory to develop a comprehensive

The life science ecosystem is a complex organism being influenced by patients, providers, payers, and regulators in the precision medicine,